Page last updated: 2024-08-21

eriodictyol and Diathesis

eriodictyol has been researched along with Diathesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Du, Q; Lai, YJ; Li, L; Li, WJ; Liu, QL; Liu, SQ; Zheng, XR	1

Other Studies

1 other study(ies) available for eriodictyol and Diathesis

Article	Year
Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Molecular medicine (Cambridge, Mass.), 2022, 01-29, Volume: 28, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Biomarkers; Cognition; Disease Models, Animal; Disease Susceptibility; Female; Ferroptosis; Flavanones; Immunohistochemistry; Mice; Mice, Transgenic; NF-E2-Related Factor 2; Phosphorylation; Protein Aggregation, Pathological; Reactive Oxygen Species; Receptors, Calcitriol; Signal Transduction; tau Proteins	2022

Article

Year

Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation.

Molecular medicine (Cambridge, Mass.), 2022, 01-29, Volume: 28, Issue:1

Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Biomarkers; Cognition; Disease Models, Animal; Disease Susceptibility; Female; Ferroptosis; Flavanones; Immunohistochemistry; Mice; Mice, Transgenic; NF-E2-Related Factor 2; Phosphorylation; Protein Aggregation, Pathological; Reactive Oxygen Species; Receptors, Calcitriol; Signal Transduction; tau Proteins

2022